These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29601263)
1. Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic. Liang TJ; Ward JW N Engl J Med; 2018 Mar; 378(13):1169-1171. PubMed ID: 29601263 [No Abstract] [Full Text] [Related]
2. The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids. Mateu-Gelabert P; Guarino H Int J Drug Policy; 2018 Jul; 57():130-132. PubMed ID: 29627198 [No Abstract] [Full Text] [Related]
3. Serious Opioid Injection-Related Infection and Initiation of Medication for Opioid Use Disorder. Springer SA JAMA Netw Open; 2024 Jul; 7(7):e2421640. PubMed ID: 39046746 [No Abstract] [Full Text] [Related]
4. EASL Recommendations on Treatment of Hepatitis C 2018. ; J Hepatol; 2018 Aug; 69(2):461-511. PubMed ID: 29650333 [No Abstract] [Full Text] [Related]
5. Feasibility of reaching world health organization targets for hepatitis C and the cost-effectiveness of alternative strategies. Wisløff T; White R; Dalgard O; Amundsen EJ; Meijerink H; Kløvstad H J Viral Hepat; 2018 Sep; 25(9):1066-1077. PubMed ID: 29624813 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France. Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Mabileau G; Dhersin JS; Yazdanpanah Y J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211 [TBL] [Abstract][Full Text] [Related]
7. Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults. Morse A; Barritt AS; Jhaveri R Gastroenterology; 2018 May; 154(6):1850-1851.e2. PubMed ID: 29621519 [No Abstract] [Full Text] [Related]
8. Hepatitis B vaccination coverage among adults aged ≥ 18 years traveling to a country of high or intermediate endemicity, United States, 2015. Lu PJ; O'Halloran AC; Williams WW; Nelson NP Vaccine; 2018 Apr; 36(18):2471-2479. PubMed ID: 29605514 [TBL] [Abstract][Full Text] [Related]
9. Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system. Zhu Y; Coyle DT; Mohamoud M; Zhou E; Eworuke E; Dormitzer C; Staffa J Drug Alcohol Depend; 2018 Jun; 187():221-226. PubMed ID: 29680678 [TBL] [Abstract][Full Text] [Related]
10. Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use. Fisher KA; Cahill LM; Broyles S; Rorke M; Robinson WT PLoS One; 2018; 13(4):e0196157. PubMed ID: 29702681 [TBL] [Abstract][Full Text] [Related]
11. Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder. Trabut JB; Barrault C; Charlot H; Carmona D; Bourdel A; Benslimane M; François M; Kini-Matondo W; Causse R; Roudot-Thoraval F; Hézode C J Addict Med; 2018; 12(5):346-352. PubMed ID: 29702515 [TBL] [Abstract][Full Text] [Related]
12. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Bisaga A; Mannelli P; Yu M; Nangia N; Graham CE; Tompkins DA; Kosten TR; Akerman SC; Silverman BL; Sullivan MA Drug Alcohol Depend; 2018 Jun; 187():171-178. PubMed ID: 29674251 [TBL] [Abstract][Full Text] [Related]
13. HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Bosh KA; Coyle JR; Hansen V; Kim EM; Speers S; Comer M; Maddox LM; Khuwaja S; Zhou W; Jatta A; Mayer R; Brantley AD; Muriithi NW; Bhattacharjee R; Flynn C; Bouton L; John B; Keusch J; Barber CA; Sweet K; Ramaswamy C; Westheimer EF; VanderBusch L; Nishimura A; Vu A; Hoffman-Arriaga L; Rowlinson E; Carter AO; Yerkes LE; Li W; Reuer JR; Stockman LJ; Tang T; Brooks JT; Teshale EH; Hall HI Epidemiol Infect; 2018 May; 146(7):920-930. PubMed ID: 29636119 [TBL] [Abstract][Full Text] [Related]
14. Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment. Kowalczyk WJ; Moran LM; Bertz JW; Phillips KA; Ghitza UE; Vahabzadeh M; Lin JL; Epstein DH; Preston KL Am J Drug Alcohol Abuse; 2018; 44(5):502-511. PubMed ID: 29634425 [TBL] [Abstract][Full Text] [Related]
15. 12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Houssel-Debry P; Coilly A; Fougerou-Leurent C; Jezequel C; Duvoux C; De Ledinghen V; Radenne S; Kamar N; Leroy V; Martino VD; D'Alteroche L; Canva V; Conti F; Dumortier J; Montialoux H; Lebray P; Botta-Fridlund D; Tran A; Moreno C; Silvain C; Besch C; Perre P; Francoz C; Abergel A; Habersetzer F; Debette-Gratien M; Cagnot C; Diallo A; Chevaliez S; Rossignol E; Veislinger A; Duclos-Vallee JC; Pageaux GP; Hepatology; 2018 Oct; 68(4):1277-1287. PubMed ID: 29633389 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada. Klimas J; Nosova E; Socías E; Nolan S; Brar R; Hayashi K; Milloy MJ; Kerr T; Wood E Drug Alcohol Depend; 2018 May; 186():182-186. PubMed ID: 29604525 [TBL] [Abstract][Full Text] [Related]
17. Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein. Bi X; Tong S Virology; 2018 May; 518():358-368. PubMed ID: 29604477 [TBL] [Abstract][Full Text] [Related]
18. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland. Patel EU; Grieb SM; Winiker AK; Ching J; Schluth CG; Mehta SH; Kirk GD; Genberg BL Harm Reduct J; 2024 May; 21(1):91. PubMed ID: 38720307 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study. Kumar A; Mahajan H; Chaturvedi S; Kumar A; Kumar S; Sahoo GC; Das VNR; Pandey K PLoS One; 2023; 18(6):e0287333. PubMed ID: 37319276 [TBL] [Abstract][Full Text] [Related]
20. Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C. Jiang X; Song HJ; Chang CY; Wilson DL; Lo-Ciganic WH; Park H Med Care; 2023 Aug; 61(8):505-513. PubMed ID: 37223993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]